Nucynta ER 200 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FUQGE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,412
Award facts
- Contract value 100% obligated
- $2,411.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The delivery order supports the Defense Logistics Agency's medical supply chain operations, which procures pharmaceuticals and medical commodities for military and veteran healthcare systems. Nucynta ER (tapentadol extended-release) is a centrally acting analgesic used in pain management protocols across Department of Defense healthcare facilities. AmerisourceBergen's extensive federal contract portfolio and its status as a competitively selected prime vendor demonstrate the company's capability to meet critical federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DB25FUQGE?
SPE2DB25FUQGE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FUQGE worth?
The government has obligated $2,412 on SPE2DB25FUQGE.
Is contract SPE2DB25FUQGE an order under another contract?
Yes. SPE2DB25FUQGE is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQGE competed?
The extent of competition for SPE2DB25FUQGE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award